Walker A M, Funch D P, Sulsky S I, Dreyer N A
Epidemiology Resources, Inc., Newton Lower Falls, Mass 02162-1450, USA.
Circulation. 1995 Dec 1;92(11):3235-9. doi: 10.1161/01.cir.92.11.3235.
Previously established predictors of outlet strut fracture in Björk-Shiley convexo-concave (CC) valves include larger valve size, larger opening angle (70 degrees versus 60 degrees), younger age at implant, and date of manufacture. We sought to identify patient characteristics that might be predictive of strut fracture and to refine the estimates associated with previously identified predictors.
We conducted a case-control study of CC60 degrees valves implanted in the United States and Canada and manufactured between January 1, 1979, and March 31, 1984. Cases included all valves with verified outlet strut fractures reported to the manufacturer from January 1979 through January 1992. Up to 10 controls were selected for each case. Control valves were matched according to implanting surgeon and were required to have been functioning at least as long as their matched case valves. Case and control medical records were reviewed for information on patient medical history before the valve implant. There were 96 case and 634 control valves for which clinical data were available. Patient age and valve size and implant position were confirmed as important determinants of fracture. There was a strong inverse gradient of risk with age. The risk of fracture was 42% lower for each 10-year increment of patient age at time of implant. Large mitral valves were at greatest risk of strut fracture, with the largest mitral valves (33 mm) estimated to be 33 times more likely to fracture than the smallest (21 to 25 mm) aortic valves. Date of manufacture was also associated with risk; valves welded from mid-1981 through March 1984 were more likely to fracture than those manufactured in 1979 and 1980. Body surface area < 1.5 m2 was associated with 1/16 the risk of body surface area > or = 2.0 m2. No other patient factor was strongly associated with the risk of strut fracture.
Few patient features identifiable in the implant record are predictive of strut fracture. Our analysis supports previous work in identifying valve size, patient age, and date of manufacture as predictors of fracture and adds body surface area. A number of these associations suggest that conditions associated with higher cardiac output may also place patients at increased risk.
此前确定的 Björk-Shiley 凸凹(CC)型瓣膜出口支柱骨折的预测因素包括瓣膜尺寸较大、开口角度较大(70 度对比 60 度)、植入时年龄较小以及制造日期。我们试图确定可能预测支柱骨折的患者特征,并完善与先前确定的预测因素相关的估计值。
我们对 1979 年 1 月 1 日至 1984 年 3 月 31 日在美国和加拿大植入的 CC60 度瓣膜进行了病例对照研究。病例包括 1979 年 1 月至 1992 年 1 月期间向制造商报告的所有经证实有出口支柱骨折的瓣膜。每个病例最多选择 10 个对照。对照瓣膜根据植入外科医生进行匹配,并且要求其功能至少与匹配的病例瓣膜一样长。回顾病例和对照的医疗记录,以获取瓣膜植入前患者病史的信息。有 96 个病例瓣膜和 634 个对照瓣膜有可用的临床数据。患者年龄、瓣膜尺寸和植入位置被确认为骨折的重要决定因素。风险与年龄呈强烈的负梯度。植入时患者年龄每增加 10 岁,骨折风险降低 42%。大型二尖瓣发生支柱骨折的风险最高,最大的二尖瓣(33 毫米)估计发生骨折的可能性是最小的主动脉瓣(21 至 25 毫米)的 33倍。制造日期也与风险相关;1981 年年中至 1984 年 3 月焊接的瓣膜比 1979 年和 1980 年制造的瓣膜更易骨折。体表面积<1.5平方米的患者发生骨折的风险是体表面积≥2.0平方米患者的十六分之一。没有其他患者因素与支柱骨折风险密切相关。
在植入记录中可识别的患者特征很少能预测支柱骨折。我们的分析支持先前将瓣膜尺寸、患者年龄和制造日期确定为骨折预测因素的工作,并增加了体表面积这一因素。其中一些关联表明,与较高心输出量相关的情况也可能使患者风险增加。